PHAXIAM THERAPEUTICS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.95 EUR | +1.20% |
|
0.00% | -35.87% |
Chart calendar PHAXIAM Therapeutics S.A.
18fea6c3.Zwe1LvABN7G8tOHDck2i3yfilTbLDYhl4Wqjqj6sA7I.VF_yGKJuc_zT_NiUET-PpniU0myneMlUlTzS6VSaUN0INtxawzRR3_L22Q~30a87ffc364d8c06fb529423f3a6ee8f
Upcoming events on PHAXIAM Therapeutics S.A.
Past events on PHAXIAM Therapeutics S.A.
| 2024-03-21 09:30 am | Q4 2023 Earnings Call |
| 2024-03-20 01:00 pm | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 5,28 5,46 -3.25% | 3,72 7,69 -51.63% | 4,18 7,95 -47.4% | 31,0 9,20 236.93% | 0,00 0,00 - | 1,05 |
|
EBITDA Million EUR | Released Forecast Spread | -59,9 -51,2 -16.99% | -63,8 -32,6 -95.83% | -51,1 -70,4 27.36% | 1,82 -52,6 103.47% | 0,00 -25,3 - | -17,5 |
|
EBIT Million EUR | Released Forecast Spread | -64,1 -58,0 -10.4% | -68,8 -62,4 -10.24% | -56,5 -62,9 10.12% | -2,80 -52,6 94.68% | -23,7 -25,9 8.65% | 1,00 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -62,7 -57,7 -8.52% | -73,3 -63,7 -15.06% | -53,8 -57,3 6.18% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million EUR | Released Forecast Spread | -62,7 -57,5 -8.92% | -73,3 -63,7 -15.06% | -53,8 -62,1 13.41% | -0,23 -52,8 99.57% | -23,5 -26,0 9.66% | -0,90 |
|
EPS EUR | Released Forecast Spread | -34,9 -29,6 -17.73% | -39,9 -29,1 -37.11% | -22,7 -39,0 41.79% | -0,10 -22,3 99.55% | 0,00 -4,28 - | -1,41 |
| Announcement Date | 16/03/20 | 08/03/21 | 27/04/22 | 22/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 S1 | 2022 Q3 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2,32 2,60 -10.85% | 1,85 1,60 15.56% | 1,87 1,90 -1.63% | 2,27 1,10 106.36% | 0,96 1,25 -23.2% | 0,54 1,75 -69.2% | 0,47 | |
|
EBITDA Million EUR | Released Forecast Spread | -30,7 -27,1 -13.31% | -33,6 -28,5 -18% | -31,0 -31,3 1.02% | -26,5 -31,0 14.61% | ||||
|
EBIT Million EUR | Released Forecast Spread | -33,8 -28,4 -19.12% | -35,4 -30,2 -17.12% | -33,5 -31,7 -5.56% | -29,0 -33,7 14.05% | -13,8 -14,1 2.61% | -12,5 -13,7 8.35% | ||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -33,4 -28,2 -18.35% | -35,0 -30,3 -15.39% | -38,3 -31,6 -21.31% | -28,0 -34,6 19.22% | -14,0 | -11,9 -13,6 12.37% | ||
|
Net income Million EUR | Released Forecast Spread | -33,4 -28,2 -18.34% | -35,0 -30,3 -15.39% | -38,3 -31,6 -21.32% | -28,0 -34,6 19.21% | -14,0 | -11,9 -13,6 12.37% | -1,02 | -5,14 |
|
EPS EUR | Released Forecast Spread | -18,6 -16,0 -16.25% | -19,5 -17,0 -14.71% | -20,4 -17,0 -20% | -12,2 -17,0 28.24% | -0,30 | |||
| Announcement Date | 16/03/20 | 21/09/20 | 08/03/21 | 20/09/21 | 27/04/22 | 12/05/22 | 12/09/22 | 21/11/22 |
More events
Past sector events for PHAXIAM Therapeutics S.A.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHXM Stock
- PHXM Stock
- Calendar PHAXIAM Therapeutics S.A.
